Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Asset Utilization Ratio (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Asset Utilization Ratio for 15 consecutive years, with 1.15 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 44.69% to 1.15 in Q4 2025 year-over-year; TTM through Dec 2025 was 1.15, a 44.69% increase, with the full-year FY2025 number at 0.95, up 23.41% from a year prior.
  • Asset Utilization Ratio was 1.15 for Q4 2025 at Myriad Genetics, down from 1.17 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.17 in Q3 2025 to a low of 0.52 in Q1 2021.
  • A 5-year average of 0.7 and a median of 0.61 in 2021 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: surged 46.72% in 2021, then decreased 11.26% in 2022.
  • Myriad Genetics' Asset Utilization Ratio stood at 0.52 in 2021, then increased by 8.25% to 0.56 in 2022, then rose by 16.59% to 0.66 in 2023, then grew by 21.05% to 0.79 in 2024, then skyrocketed by 44.69% to 1.15 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Asset Utilization Ratio are 1.15 (Q4 2025), 1.17 (Q3 2025), and 0.99 (Q2 2025).